Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

10052	Companies
205146	Keywords
135404	Articles
108776	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 08/12/2025 at 15:05, 7 months 6 days ago

Jaguar Health Announces Investor Webcast on August 14, 2025

Financial Results Pharmaceuticals Investor Webcast Jaguar Health Lisa Conte
PRESS RELEASE

published on 08/12/2025 at 15:00, 7 months 6 days ago

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Jaguar Health, Inc. to conduct investor webcast on August 14, 2025 to review Q2 financials and corporate updates. CEO Lisa Conte presenting at Emerging Growth Conference on August 20, 2025

Investor Webcast Lisa Conte Emerging Growth Conference Jaguar Health Inc. Q2 Financials
BRIEF

published on 07/10/2025 at 14:35, 8 months 8 days ago

Jaguar Health Expands Study on Canalevia-CA1 for Dogs

FDA Approval Jaguar Health Canalevia-CA1 Animal Health Dog Diarrhea
PRESS RELEASE

published on 07/10/2025 at 14:30, 8 months 8 days ago

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Jaguar Health, Inc. in talks with animal health partners to bring Canalevia to global market for general diarrhea in dogs. CEO presents at conference to discuss updates on Canalevia-CA1

Jaguar Health Conference Canalevia Animal Health Partners General Diarrhea
BRIEF

published on 07/08/2025 at 15:05, 8 months 10 days ago

Peru Grants Coca Research Rights to Magdalena Biosciences

Mental Health Jaguar Health Magdalena Biosciences Coca Research Peru Partnership
PRESS RELEASE

published on 07/08/2025 at 15:00, 8 months 10 days ago

Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indic
Jaguar Health announces agreement for research on coca plants to develop plant-based drugs for mental health and CNS indications, focusing on fair benefits sharing and traditional medicine

Mental Health Jaguar Health Coca Plants Plant-based Drugs Benefits Sharing
BRIEF

published on 06/30/2025 at 15:05, 8 months 18 days ago

Jaguar Health's Crofelemer Shows Promising Results in Reducing Parenteral Nutrition

Crofelemer Jaguar Health Regulatory Approvals Intestinal Failure Parenteral Nutrition
PRESS RELEASE

published on 06/30/2025 at 15:00, 8 months 18 days ago

Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
Initial proof-of-concept results show crofelemer's efficacy in reducing TPN for intestinal failure patients. Jaguar seeking partnerships for drug development and commercialization

Crofelemer Drug Development Jaguar Health TPN Reduction Intestinal Failure
BRIEF

published on 06/30/2025 at 14:29, 8 months 18 days ago

Jaguar Health: FDA Dialogue and Strategic Trials

Crofelemer Clinical Trials Jaguar Health Breast Cancer FDA Meeting
PRESS RELEASE

published on 06/30/2025 at 14:24, 8 months 18 days ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Jaguar Health Inc (ISIN: US47010C8055) to USD 40 target price post-positive breast cancer trial subgroup results. Plans for FDA approval through pivotal trial and orphan drug designation

Jaguar Health Inc FDA Approval First Berlin Equity Research Orphan Drug Designation Pivotal Trial

Accesswire

Published on 03/19/2026 at 07:30, 20 minutes ago

Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential
Published on 03/19/2026 at 06:35, 1 hour 15 minutes ago

Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 6 hours 45 minutes ago

Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 8 hours 5 minutes ago

Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 10 hours 50 minutes ago

PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie

View all ACCESSWIRE

EQS Group

Published on 03/19/2026 at 07:35, 15 minutes ago

Lenzing advances its transformation: Higher EBITDA, stronger free cash flow and more than EUR 200 million in cost savings
Published on 03/19/2026 at 07:30, 20 minutes ago

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
Published on 03/19/2026 at 07:30, 20 minutes ago

The Nordex Group receives orders totaling 54 MW from Prowind in Germany
Published on 03/19/2026 at 07:30, 20 minutes ago

Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Published on 03/19/2026 at 07:30, 20 minutes ago

SGL Carbon: Restructuring ensures earnings forecast and creates basis for new growth

Les Echos

Published on 03/19/2026 at 07:00, 50 minutes ago

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 50 minutes ago

2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 12 hours 8 minutes ago

Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 13 hours 50 minutes ago

Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 14 hours 5 minutes ago

Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.

View all LES ECHOS COMFI WIRE